IN June last year the Irish Government signed-off on its five-year medicinal cannabis programme - but no patients have yet been enrolled.
However, there is...
A LACK of clinical evidence is a key reason the National Health Service offers for the paucity of medicinal cannabis prescriptions in the UK.
So, one...
A WORLD-LEADING cannabis professor says the UK is caught in a depressing Catch-22 with companies unwilling to invest in clinical trials and medics unwilling...
THE typical patient at Sapphire Medical Clinics is a 65-year-old lady using cannabis medicine for chronic pain.
This chimes with Germany - Europe’s largest medicinal...
THE local corner shop has never been so busy, with stock squeezed into every conceivable corner a former struggling business has been transformed and...
PRESS RELEASE
FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...